Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under several brand names, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe, and other countries. The company is headquartered in Foster City, California, the US.Scope
- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Gilead Sciences, Inc.: Company Overview
- Gilead Sciences, Inc.: Overview and Key Facts
- Gilead Sciences, Inc.: Overview
- Gilead Sciences, Inc.: Key Facts
- Gilead Sciences, Inc.: Key Employees
- Gilead Sciences, Inc.: Key Employee Biographies
- Gilead Sciences, Inc.: Major Products and Services
- Gilead Sciences, Inc.: Management Statement
- Gilead Sciences, Inc.: Locations and Subsidiaries
- Gilead Sciences, Inc.: Key Competitors
- Gilead Sciences, Inc.: Company Analysis
- Gilead Sciences, Inc.: Business Description
- Gilead Sciences, Inc.: SWOT Analysis
- Gilead Sciences, Inc.: SWOT Overview
- Gilead Sciences, Inc.: Strengths
- Gilead Sciences, Inc.: Weaknesses
- Gilead Sciences, Inc.: Opportunities
- Gilead Sciences, Inc.: Threats
- Gilead Sciences, Inc.: Corporate Financial Deals Activity
- Gilead Sciences, Inc.: Financial Deals Overview
- Gilead Sciences, Inc.: Targets and Partners
- Gilead Sciences, Inc.: Top Deals 2019 - 2023YTD*
- Gilead Sciences, Inc.: Advisors
- Gilead Sciences, Inc.: Top Legal Advisors
- Gilead Sciences, Inc.: Top Financial Advisors
- Gilead Sciences, Inc.: Mergers and Acquisitions
- Gilead Sciences, Inc.: Corporate Venturing
- Gilead Sciences, Inc.: Capital Raising
- Gilead Sciences, Inc.: Partnership
- Gilead Sciences, Inc.: Divestments
- Gilead Sciences, Inc.: Recent Developments
- Gilead Sciences, Inc.: News and Events Summary
- Gilead Sciences, Inc.: Contracts
- Gilead Sciences, Inc.: Market Developments
- Gilead Sciences, Inc.: Research & Development
- Gilead Sciences, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 4: Gilead Sciences, Inc.: Key Competitors
Table 5: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Gilead Sciences, Inc.: Targets and Partners
Table 10: Gilead Sciences, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Gilead Sciences, Inc.: News and Events Summary
Table 23: Gilead Sciences, Inc.: Contracts
Table 24: Gilead Sciences, Inc.: Market Developments
Table 25: Gilead Sciences, Inc.: Research & Development
Table 26: Gilead Sciences, Inc.: Strategy and Operations
List of Figures
Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
